Drive-Through Model for Anticoagulation Clinics During the COVID-19 Pandemic.
Kaveh Rezaei BookaniIva MingaManisha ChanderKsenia HankewychMatthew PlassmeierAlfonso TafurPublished in: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis (2020)
The coronavirus disease of 2019 (COVID-19) has posed a major challenge for providers and patients. A large number of patients with atrial fibrillation, venous thromboembolism, or valvular heart disease are chronically anticoagulated with vitamin K antagonists and rely on frequent follow ups at anticoagulation clinics for management of their anticoagulation therapy. The need for isolation during COVID-19 pandemic can potentially limit access to health care including anticoagulation clinics and directly affect the care of patients on chronic anticoagulation. Therefore, we created a drive-through clinic to bridge the gap of continuation of care and preservation of social distancing precautions. In this manuscript, we report the steps in implementing such initiative which can be applied to other clinics during a pandemic.
Keyphrases
- venous thromboembolism
- coronavirus disease
- healthcare
- atrial fibrillation
- primary care
- end stage renal disease
- quality improvement
- ejection fraction
- sars cov
- newly diagnosed
- direct oral anticoagulants
- palliative care
- prognostic factors
- mental health
- stem cells
- patient reported outcomes
- mesenchymal stem cells
- bone marrow
- affordable care act
- patient reported